D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects

Student Name

Western Governors University 

D027 Advanced Pathopharmacological Foundations

Prof. Name

Date

Alzheimer’s Disease Synthesis

What is Alzheimer’s Disease?

Alzheimer’s Disease (AD) is a long-term, progressive neurological condition that primarily impairs cognitive abilities such as memory, reasoning, and thinking. It represents the most prevalent form of dementia, accounting for roughly 60% to 80% of all dementia cases globally. AD poses a critical challenge to public health, especially in the United States, where it ranks as the seventh leading cause of death (National Institutes of Health [NIH], 2021). Although the disease mainly affects elderly individuals, it is important to emphasize that it is not an inevitable consequence of aging but rather a pathological disorder.

What Causes Alzheimer’s Disease? (Pathophysiology)

The precise origins of Alzheimer’s Disease remain unclear, but it is generally understood to result from a multifaceted interplay of genetic predispositions, environmental influences, and lifestyle factors. At the microscopic level, two hallmark abnormalities define AD: extracellular deposits of beta-amyloid plaques and intracellular neurofibrillary tangles formed by hyperphosphorylated tau protein (NIH, 2021). These pathological features interfere with neuronal communication, leading to synaptic dysfunction and progressive neuronal loss.

This neurodegeneration critically disrupts the production of neurotransmitters, particularly acetylcholine, which is essential for memory and learning processes. Key brain regions involved in cognition, including the hippocampus and cerebral cortex, undergo noticeable atrophy in AD patients. Furthermore, chronic neuroinflammation and an exaggerated immune response within the brain contribute to the acceleration of plaque and tangle formation, exacerbating neuronal damage and cognitive decline.

What are the Clinical Manifestations of Alzheimer’s Disease?

Alzheimer’s Disease progresses through gradual stages—mild (early), moderate, and severe (late)—with distinct clinical features emerging over time. Prior to the clear onset of these stages, there are ten warning signs that can help identify the disease early. Recognizing these early symptoms is vital for timely diagnosis and intervention.

The progression of AD can span several years, with average life expectancy after diagnosis ranging from four to eight years, though some individuals live up to two decades, depending on health, disease severity, and quality of care.

Several risk factors increase the likelihood of developing Alzheimer’s Disease. These include advanced age, history of traumatic brain injury, hypertension, diabetes, obesity, and smoking. Epidemiological studies have also found that women have a higher risk than men, and African Americans face approximately double the risk compared to other ethnic groups.

How is Alzheimer’s Disease Diagnosed?

The diagnosis of Alzheimer’s Disease involves a comprehensive, multi-step approach that integrates clinical assessments with diagnostic testing. Initially, healthcare professionals collect extensive patient history, including lifestyle habits and any observed cognitive or behavioral changes.

Cognitive assessments are performed to evaluate memory, attention, language, problem-solving, and orientation, distinguishing AD from other causes of dementia. To exclude other potential causes of cognitive impairment, laboratory tests such as blood and urine analyses are conducted.

Imaging techniques like computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans are crucial for identifying brain atrophy and amyloid plaque accumulation, supporting the clinical diagnosis (NIH, 2021). These tools help rule out other neurological conditions and confirm the presence of characteristic AD pathology.

References

National Institutes of Health. (2021). Alzheimer’s disease fact sheet. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet

Western Governors University. (n.d.). Alzheimer’s disease. Panopto. https://wgu.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=f280f008-5d8e-42b3-8f7ead8a00f1a105

United Health Foundation. (2022). Explore colorectal cancer screening in Virginia: 2021 annual report. America’s Health Rankings. https://www.americashealthrankings.org/explore/annual/measure/colorectal_cancer_screening/state/VA